Drug Markets/Ribociclib

Ribociclib

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Ribociclib is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Ribociclib is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $289.72 to $346.95 per EA — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$289.72 – $346.95

per EA

7d Activity

2 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing RIBOCICLIB

Drug Portfolio

2 NDCs total, 2 shown

Drug ↕Price 7d Change ↕
KISQALI 400 MG DAILY DOSE
$346.9469
per EA
—
KISQALI 600 MG DAILY DOSE
$289.7167
per EA
—

Frequently Asked Questions

What is Ribociclib used to treat?

Ribociclib is used to treat breast neoplasms, per the National Library of Medicine's MED-RT classification.

How many Ribociclib products are on the market?

The Ribociclib drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Ribociclib?

NADAC reference prices for Ribociclib range from $289.7167 to $346.9469 per EA — a 20% difference between cheapest and most expensive.

Which manufacturers make Ribociclib?

1 manufacturer lists Ribociclib in NADAC. Ranked by number of NDCs, the largest are Novartis Pharmaceuticals Corporation (2).